IRF5 proved to be an adverse independent prognostic factor for overall survival (OS) and recurrence free survival (RFS) in clear cell renal cell carcinoma (ccRCC) cells (27). This evidence concerns the gene IRF5 and nonpapillary renal cell carcinoma.